MIP
MR

Mondrian Investment Partners’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Mondrian Investment Partners’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,543,600
Closed -$286M – 150
2015
Q4 		$286M Sell
10,543,600
-244,600
-2% -$6.3M 6.29% 1
2015
Q3 		$236M Sell
10,788,200
-264,300
-2% -$6.75M 5% 4
2015
Q2 		$315M Sell
11,052,500
-141,000
-1% -$4.11M 5.34% 4
2015
Q1 		$306M Buy
11,193,500
+275,600
+3% +$7.59M 5% 4
2014
Q4 		$288M Buy
10,917,900
+305,900
+3% +$8.95M 4.64% 5
2014
Q3 		$320M Buy
10,612,000
+61,600
+0.6% +$1.91M 4.45% 6
2014
Q2 		$332M Buy
10,550,400
+248,700
+2% +$7.89M 4.67% 6
2014
Q1 		$333M Buy
10,301,700
+484,632
+5% +$17M 4.89% 4
2013
Q4 		$357M Buy
9,817,068
+1,535,968
+19% +$59.7M 5% 3
2013
Q3 		$322M Buy
8,281,100
+208,000
+3% +$8.38M 4.75% 5
2013
Q2 		$302M Buy
+8,073,100
New +$319M 4.6% 5

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mondrian Investment Partners's MR Position: Q1 2016 in Review

Mondrian Investment Partners sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 10,543,600 shares — an estimated $286M sold.

Mondrian Investment Partners first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $357M in Q4 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Mondrian Investment Partners reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Mondrian Investment Partners sold 10,543,600 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $286M.
  • Mondrian Investment Partners first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Mondrian Investment Partners's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $357M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Mondrian Investment Partners's 13F filing for Q1 2016, filed 4 May 2016.